Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing
Swiss tech-bio firm Atlas Bio today launched from stealth with a $10 million Seed round led by Creandum, alongside a previously unannounced pre-Seed round led by First Momentum Ventures and LEA Partne...
We haven't written up this one. Tech.eu has the full story — the link below goes straight to it.